There are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...

Shigella Spreading in Kerala? Kerala has intensified surveillance and testing following its first reported Shigella-related death of a four...

A gap in science-backed skincare products in the Indian market prompted Shaily Mehrotra to start Fixderma, with an aim to solve common skin...

For the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...

The National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices for 30 essential drug formulations, including those for diabet...

After the correction, the street will reach a stage where, if a company delivers numbers, there will be enough money waiting to move into t...

Bryan Johnson has claimed that frequent international travel may be harmful for the human body, calling it “barbaric” in a recent X post. S...

Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...

The World Health Organization has declared an international health emergency over an Ebola outbreak in the Democratic Republic of Congo. Th...

Here’s a thing investors in equity need to keep in mind. A large part of the upmove one might see in the next one or two trading sessions w...

Pfizer is prioritizing India for future growth. The company plans to launch new medicines here soon after their global release. Pfizer aims...

A hantavirus outbreak on a cruise ship has sparked public concern. Health officials are working to communicate clearly, drawing lessons fro...

Venus Remedies has received approval in Argentina for its antibiotic Ceftriaxone. This marks a significant step in the company's Latin Amer...

As far as India is concerned, the biggest pain point from the US-Iran war in the Gulf region has been the spike in the prices of not only o...

The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...

Alkem Labs, a leading Indian drug maker, is set for a top management change. Vikas Gupta, the CEO for nearly three years, is expected to de...

Quadria Capital is eyeing a strategic acquisition of a majority interest in Samarth Lifesciences, a move that could value the transaction a...